[Retracted] Short- and Long-Term Influences of Benzodiazepine and Z-Drug Use in Patients with Bipolar Disorder Combined Sleep Disturbance during Affective Period: A Nine-Month Follow-Up Analysis

Table 2

Treatment characteristics of BZD/Z-drugs.

	BZDs/Z-drugs	Number (%)	Male (%)	Female (%)
Short-acting BZDs	Total number	13 (100.0%)	5 (38.5%)	8 (61.5%)	2.847	0.090
	Alprazolam	3 (23.1%)	0 (0.0%)	3 (23.1%)	4.810	0.057
	Lorazepam	9 (69.2%)	4 (30.8%)	5 (38.5%)	1.121	0.304
	Estazolam	1 (7.7%)	1 (7.7%)	0 (0.0%)	0.660	0.606
Long-acting BZDs	Clonazepam	30 (100.0%)	20 (66.7%)	10 (33.3%)	0.810	0.463
Z-drugs	Total number	3 (100.0%)	2 (66.7%)	1 (33.3%)	0.076	0.636
	Zolpidem	2 (66.7%)	1 (33.3%)	1 (33.3%)	0.096	0.637
	Zopiclone	1 (33.3%)	1 (33.3%)	0 (0.0%)	0.660	0.606

BZDs: benzodiazepines.